The pathogenetic and prognostic value of biologic markers in acute lung injury (Q37413838)

20 August 2017

1 reference

title

The pathogenetic and prognostic value of biologic markers in acute lung injury (English)

1 reference

20 August 2017

0 references

4

Michael A Matthay

1 reference

20 August 2017

Joseph E Levitt

1

1 reference

20 August 2017

Michael K Gould

series ordinal

2

1 reference

20 August 2017

Loraine B Ware

series ordinal

3

1 reference

20 August 2017

publication date

11 March 2009

1 reference

Journal of Intensive Care Medicine

20 August 2017

published in

1 reference

20 August 2017

volume

24

1 reference

20 August 2017

issue

3

1 reference

20 August 2017

page(s)

151-167

1 reference

Plasma surfactant protein levels and clinical outcomes in patients with acute lung injury

20 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0885066609332603

Lower tidal volume ventilation and plasma cytokine markers of inflammation in patients with acute lung injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609332603

Elevated plasma levels of soluble TNF receptors are associated with morbidity and mortality in patients with acute lung injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609332603

Significance of von Willebrand factor in septic and nonseptic patients with acute lung injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609332603

Protein C and thrombomodulin in human acute lung injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609332603

Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609332603

Effect of prone positioning on the survival of patients with acute respiratory failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609332603

Inhalation of nitric oxide in acute lung injury: results of a European multicentre study. The European Study Group of Inhaled Nitric Oxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609332603

Effect of recombinant surfactant protein C-based surfactant on the acute respiratory distress syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609332603

Low-dose inhaled nitric oxide in patients with acute lung injury: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609332603

A multi-centre, double-blind, placebo-controlled study of liposomal prostaglandin E1 (TLC C-53) in patients with acute respiratory distress syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609332603

Treatment of acute lung injury: historical perspective and potential future therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609332603

Comparison of two fluid-management strategies in acute lung injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609332603

Biological markers of acute lung injury: prognostic and pathogenetic significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609332603

von Willebrand factor antigen levels are not predictive for the adult respiratory distress syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609332603

Trauma-associated lung injury differs clinically and biologically from acute lung injury due to other clinical disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609332603

Soluble intercellular adhesion molecule-1 and clinical outcomes in patients with acute lung injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609332603

Plasma receptor for advanced glycation end products and clinical outcomes in acute lung injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609332603

Higher urine desmosine levels are associated with mortality in patients with acute lung injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609332603

Higher urine nitric oxide is associated with improved outcomes in patients with acute lung injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609332603

Elevated von Willebrand factor antigen is an early plasma predictor of acute lung injury in nonpulmonary sepsis syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609332603

von Willebrand factor antigen is an independent marker of poor outcome in patients with early acute lung injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609332603

Endothelial cell activity varies in patients at risk for the adult respiratory distress syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609332603

Soluble form of P-selectin in plasma is elevated in acute lung injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609332603

Elevated pulmonary edema fluid concentrations of soluble intercellular adhesion molecule-1 in patients with acute lung injury: biological and clinical significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609332603

The predictive role of serum and bronchoalveolar lavage cytokines and adhesion molecules for acute respiratory distress syndrome development and outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609332603

Early elevation of plasma soluble intercellular adhesion molecule-1 in pediatric acute lung injury identifies patients at increased risk of death and prolonged mechanical ventilation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609332603

Biomarkers of inflammation, coagulation and fibrinolysis predict mortality in acute lung injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609332603

Vascular endothelial growth factor synthesis in the acute phase of experimental and clinical lung injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609332603

A role for vascular endothelial growth factor in acute and resolving lung injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609332603

Decreased VEGF concentration in lung tissue and vascular injury during ARDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609332603

VEGF levels in the alveolar compartment do not distinguish between ARDS and hydrostatic pulmonary oedema

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609332603

Excess circulating angiopoietin-2 may contribute to pulmonary vascular leak in sepsis in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609332603

Hyperoxia causes angiopoietin 2-mediated acute lung injury and necrotic cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609332603

Prognostic value of surfactant proteins A and D in patients with acute lung injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609332603

Receptor for advanced glycation end-products is a marker of type I cell injury in acute lung injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609332603

Plasma receptor for advanced glycation end-products predicts duration of ICU stay and mechanical ventilation in patients after lung transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609332603

Elevation of KL-6, a lung epithelial cell marker, in plasma and epithelial lining fluid in acute respiratory distress syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609332603

Urinary desmosine excretion as a marker of lung injury in the adult respiratory distress syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609332603

Urinary desmosine as a biomarker in acute lung injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609332603

The adult respiratory distress syndrome. Cell populations and soluble mediators in the air spaces of patients at high risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609332603

Elevated levels of NAP-1/interleukin-8 are present in the airspaces of patients with the adult respiratory distress syndrome and are associated with increased mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609332603

Macrophages and polymorphonuclear neutrophils in lung defense and injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609332603

Elevated levels of plasminogen activator inhibitor-1 in pulmonary edema fluid are associated with mortality in acute lung injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609332603

Initial serum ferritin levels in patients with multiple trauma and the subsequent development of acute respiratory distress syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609332603

Pulmonary edema fluid antioxidants are depressed in acute lung injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609332603

Early detection of type III procollagen peptide in acute lung injury. Pathogenetic and prognostic significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609332603

Soluble transforming growth factor-alpha is present in the pulmonary edema fluid of patients with acute lung injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609332603

Elevated transforming growth factor-alpha levels in bronchoalveolar lavage fluid of patients with acute respiratory distress syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609332603

Hepatocyte growth factor and keratinocyte growth factor in the pulmonary edema fluid of patients with acute lung injury. Biologic and clinical significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609332603

Fas and fas ligand are up-regulated in pulmonary edema fluid and lung tissue of patients with acute lung injury and the acute respiratory distress syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609332603

The acute respiratory distress syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609332603

Fibrin induces release of von Willebrand factor from endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609332603

Changes in cytosolic Ca2+ associated with von Willebrand factor release in human endothelial cells exposed to histamine. Study of microcarrier cell monolayers using the fluorescent probe indo-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609332603

Endothelial signalling events during leukocyte transmigration

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609332603

Vascular endothelial growth factor (VEGF) in acute lung injury (ALI) and acute respiratory distress syndrome (ARDS): paradox or paradigm?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609332603

Alveolar fluid clearance is impaired in the majority of patients with acute lung injury and the acute respiratory distress syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609332603

Surfactant and the adult respiratory distress syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609332603

Pathogenesis of septic shock in Pseudomonas aeruginosa pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609332603

Pathogenesis of fibrosis in acute lung injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609332603

Immunomodulatory roles of surfactant proteins A and D: implications in lung disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609332603

Acute respiratory distress in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609332603

Receptor for advanced glycation end-products is a marker of type I lung alveolar cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609332603

Receptor for advanced glycation end products (RAGE) regulates sepsis but not the adaptive immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609332603

Pathogenetic significance of biological markers of ventilator-associated lung injury in experimental and clinical studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609332603

Neutrophils and host defense

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609332603

The adult respiratory distress syndrome: definition and prognosis, pathogenesis and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609332603

Adult respiratory distress syndrome in patients with severe neutropenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609332603

Effects of leukotriene B4 in the human lung. Recruitment of neutrophils into the alveolar spaces without a change in protein permeability

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609332603

Acute lung injury. Pathogenesis of intraalveolar fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609332603

Wound macrophages express TGF-alpha and other growth factors in vivo: analysis by mRNA phenotyping

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609332603

Transforming growth factor-alpha: a more potent angiogenic mediator than epidermal growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609332603

Respiratory epithelial cell expression of human transforming growth factor-alpha induces lung fibrosis in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609332603

Disturbed alveolar fibrin turnover during pneumonia is restricted to the site of infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609332603

The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609332603

Local activation of coagulation and inhibition of fibrinolysis in the lung during ventilator associated pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609332603

Efficacy and safety of recombinant human activated protein C for severe sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609332603

Activated protein C mediates novel lung endothelial barrier enhancement: role of sphingosine 1-phosphate receptor transactivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609332603

Activated protein C inhibits local coagulation after intrapulmonary delivery of endotoxin in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609332603

Drotrecogin alfa (activated) for adults with severe sepsis and a low risk of death

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609332603

Severe community-acquired pneumonia as a cause of severe sepsis: data from the PROWESS study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609332603

Randomized clinical trial of activated protein C for the treatment of acute lung injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609332603

Effect of prolonged methylprednisolone therapy in unresolving acute respiratory distress syndrome: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609332603

Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609332603

Keratinocyte and hepatocyte growth factors in the lung: roles in lung development, inflammation, and repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609332603

Wading into the genomic pool to unravel acute lung injury genetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609332603

Haemodynamic and endocrine effects of type 1 angiotensin II receptor blockade in patients with hypoxaemic cor pulmonale

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609332603

Angiotensin converting enzyme insertion/deletion polymorphism is associated with susceptibility and outcome in acute respiratory distress syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609332603

Pre-B-cell colony-enhancing factor as a potential novel biomarker in acute lung injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609332603

21 January 2018

Identifiers

DOI

10.1177/0885066609332603

1 reference

20 August 2017

1 reference